2-ethylhydracrylic aciduria in short/branched-chain acyl-CoA dehydrogenase deficiency:: Application to diagnosis and implications for the R-pathway of isoleucine oxidation

被引:30
作者
Korman, SH
Andresen, BS
Zeharia, A
Gutman, A
Boneh, A
Pitt, JJ
机构
[1] Hadassah Hebrew Univ Med Ctr, Dept Clin Biochem, Jerusalem, Israel
[2] Aarhus Univ Hosp, Res Unit Mol Med, DK-8000 Aarhus, Denmark
[3] Skejby Sygehus, Fac Hlth Sci, DK-8200 Aarhus, Denmark
[4] Aarhus Univ, Inst Human Genet, DK-8000 Aarhus, Denmark
[5] Tel Aviv Univ, Sackler Sch Med, Schneider Childrens Med Ctr Israel, Day Hospitalizat Unit, IL-49100 Petah Tiqwa, Israel
[6] Murdoch Childrens Res Inst, Genet Hlth Serv Victoria, Melbourne, Vic, Australia
关键词
D O I
10.1373/clinchem.2004.043265
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Isolated excretion of 2-methylbutyrylglycine (2-MBG) is the hallmark of short/branched-chain acyl-CoA dehydrogenase deficiency (SBCADD), a recently identified defect in the proximal pathway of L-isoleucine oxidation. SBCADD might be underdiagnosed because detection and recognition of urine acylglycines is problematic. Excretion of 2-ethylhydracrylic acid (2-EHA), an intermediate formed in the normally minor R-pathway of L-isoleucine oxidation, has not previously been described in SBCADD. Methods: Samples from four patients with 2-MBG excretion were analyzed by gas chromatography-mass spectrometry for urine organic acids, quantification of 2-MBG, and chiral determination of 2-methylbutyric acid. Blood-spot acylcarnitines were measured by electrospray-tandem mass spectrometry. Mutations in the ACADSB gene encoding SBCAD were identified by direct sequencing. Results: SBCADD was confirmed in each patient by demonstration of different ACADSB gene mutations. In multiple urine samples, organic acid analysis revealed a prominent 2-EHA peak usually exceeding the size of the 2-MBG peak. Approximately 40-46% of total 2-methylbutyric acid conjugates were in the form of the R-isomer, indicating significant metabolism via the R-pathway. Conclusions: If, as generally believed, SBCAD is responsible for R-2-MBG dehydrogenation in the R-pathway, 2-EHA would not be produced in SBCADD. Our observation Of 2-ethylhydracrylic aciduria in SBCADD implies that a different or alternative enzyme serves this function. Increased flux through the R-pathway may act as a safety valve for overflow of accumulating S-pathway metabolites and thereby mitigate the severity of SBCADD. Awareness of 2-ethylhydracrylic aciduria as a diagnostic marker could lead to increased detection of SBCADD and improved definition of its clinical phenotype. (C) 2005 American Association for Clinical Chemistry.
引用
收藏
页码:610 / 617
页数:8
相关论文
共 37 条
[1]   Isolated 2-methylbutyrylglycinuria caused by short/branched-chain acyl-CoA dehydrogenase deficiency: Identification of a new enzyme defect, resolution of its molecular basis, and evidence for distinct acyl-CoA dehydrogenases in isoleucine and valine metabolism [J].
Andresen, BS ;
Christensen, E ;
Corydon, TJ ;
Bross, P ;
Pilgaard, B ;
Wanders, RJA ;
Ruiter, JPN ;
Simonsen, H ;
Winter, V ;
Knudsen, I ;
Schroeder, LD ;
Gregersen, N ;
Skovby, F .
AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (05) :1095-1103
[2]   X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): An update [J].
Barth, PG ;
Valianpour, F ;
Bowen, VM ;
Lam, J ;
Duran, M ;
Vaz, FM ;
Wanders, RJA .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2004, 126A (04) :349-354
[3]   AN X-LINKED MITOCHONDRIAL DISEASE AFFECTING CARDIAC-MUSCLE, SKELETAL-MUSCLE AND NEUTROPHIL LEUKOCYTES [J].
BARTH, PG ;
SCHOLTE, HR ;
BERDEN, JA ;
VANDERKLEIVANMOORSEL, JM ;
LUYTHOUWEN, IEM ;
VANTVEERKORTHOF, ET ;
VANDERHARTEN, JJ ;
SOBOTKAPLOJHAR, MA .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1983, 62 (1-3) :327-355
[4]   Human long chain, very long chain and medium chain acyl-CoA dehydrogenases are specific for the S-enantiomer of 2-methylpentadecanoyl-CoA [J].
Battaile, KP ;
McBurney, M ;
Van Veldhoven, PP ;
Vockley, J .
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1998, 1390 (03) :333-338
[5]   Evaluation of urinary acylglycines by electrospray tandem mass spectrometry in mitochondrial energy metabolism defects and organic acidurias [J].
Bonafé, L ;
Troxler, H ;
Kuster, T ;
Heizmann, CW ;
Chamoles, NA ;
Burlina, AB ;
Blau, N .
MOLECULAR GENETICS AND METABOLISM, 2000, 69 (04) :302-311
[6]  
BONEH A, 2004, J INHERIT METAB D S1, V27, P98
[7]   A NEW SYNDROME WITH ETHYLMALONIC ACIDURIA AND NORMAL FATTY-ACID OXIDATION IN FIBROBLASTS [J].
BURLINA, AB ;
DIONISIVICI, C ;
BENNETT, MJ ;
GIBSON, KM ;
SERVIDEI, S ;
BERTINI, E ;
HALE, DE ;
SCHMIDTSOMMERFELD, E ;
SABETTA, G ;
ZACCHELLO, F ;
RINALDO, P .
JOURNAL OF PEDIATRICS, 1994, 124 (01) :79-86
[8]   Quantitative analysis of urinary acylglycines for the diagnosis of β-oxidation defects using GC-NCI-MS [J].
Costa, CG ;
Guérand, WS ;
Struys, EA ;
Holwerda, U ;
ten Brink, HJ ;
de Almeida, IT ;
Duran, M ;
Jakobs, C .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2000, 21 (06) :1215-1224
[9]   Problems in the detection of fatty acid oxidation defects: Experience of a quality assurance programme for qualitative urinary organic acid analysis [J].
Downing, M ;
Allen, JC ;
Bonham, JR ;
Edwards, RG ;
Manning, NJ ;
Olpin, SE ;
Pollitt, RJ .
JOURNAL OF INHERITED METABOLIC DISEASE, 1999, 22 (03) :289-292
[10]   Clinical variability in 3-hydroxy-2-methylbutyryl-CoA dehydrogenase deficiency [J].
Ensenauer, R ;
Niederhoff, H ;
Ruiter, JPN ;
Wanders, RJA ;
Schwab, KO ;
Brandis, M ;
Lehnert, W .
ANNALS OF NEUROLOGY, 2002, 51 (05) :656-659